Details werden geladen...
Amgen’s rare disease drug Tavneos tied to 20 deaths in Japan - BioSpace
The FDA has previously linked eight deaths in the U.S. to Tavneos and has alleged that doctored data were used to support its 2021 approval.
Ähnliche Seiten
FDA alignment is critical to serving the rare disease community. AI can help - BioSpace
https://www.biospace.com/drug-development/opinion-fda-alignment-is-critical-to-serving-the-rare-disease-community-ai-can-help
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
https://endpoints.news/amgen-stands-by-rare-disease-drug-tavneos-amid-japan-liver-toxicity-report/
Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development
https://www.statnews.com/2026/05/20/rare-disease-biotech-ceos-discuss-fda-uncertainty-stat-summit/
20 patients die after receiving vasculitis drug Tavneos
https://news.tuoitre.vn/20-patients-die-after-receiving-vasculitis-drug-tavneos-103260519164326169.htm
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/pr-newswire/lundbeck-receives-orphan-drug-designation-in-japan-for-asedebart-for-the-treatment-of-patients-with-congenital-adrenal-hyperplasia-and-cushings-disease/2345976